Myriad Genetics (MYGN) Appoints Paul J. Diaz as President and CEO and Member of the Board of Directors

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. HOOD
9. MU
10. IBM

Go back to Myriad Genetics (MYGN) Appoints Paul J. Diaz as President and CEO and Member of the Board of Directors

Myriad Genetics (MYGN) Tops Q4 EPS by 16c

August 13, 2020 4:12 PM EDT

Myriad Genetics (NASDAQ: MYGN) reported Q4 EPS of ($0.31), $0.16 better than the analyst estimate of ($0.47). Revenue for the quarter came in at $93.2 million versus the consensus estimate of $93.85 million.

"Following the substantial decline in test volumes at the end of Q3 and beginning... More